Beyond Air, Inc. (XAIR) Misses Q1 EPS by 10c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CHKP
5. ON
6. CRWD
7. HNGE
8. INSP
9. SPY
10. MRVL

Go back to Beyond Air, Inc. (XAIR) Misses Q1 EPS by 10c

Beyond Air® Reports Financial Results for the First Quarter of Fiscal Year 2022

August 10, 2021 4:05 PM EDT

U.S. FDA reviewing premarket approval (PMA) submission for LungFit® PH to treat persistent pulmonary hypertension of the newborn (PPHN); On track for commercial launch in the fourth quarter of calendar year 2021

Anticipate reporting interim results from the LungFit® GO Nontuberculous Mycobacteria (NTM) lung infection at-home pilot study (self-administration) in Fall 2021

Positive data presented at American Thoracic Society in May 2021 from acute viral pneumonia (including COVID-19) study using LungFit® PRO at 150 ppm NO

Solid tumor program expected to receive regulatory clearance to... More